Analyses of the genomic landscape of AML patients have discovered recurrent mutations in splicing factors SRSF2, SF3B1 and U2AF1, however these mutations are only found in approximately 10% of AML patients studied17–19. The gene discussed is SRSF2; the disease is acute myeloid leukemia.